Pretreatment with intralesional hyaluronidase prior to excision of dermatofibrosarcoma protuberans
Authors:
- 11 September 1998
- journal article
- clinical trial
- Published by Elsevier in Cancer Letters
- Vol. 131 (1) , 117-126
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1997
- The Histologic, Genetic, and Biological Relationships between Dermatofibrosarcoma Protuberans and Giant Cell FibroblastomaAdvances in Anatomic Pathology, 1997
- Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatmentJournal of the American Academy of Dermatology, 1997
- Immunoreactivity for the Human Hematopoietic Progenitor Cell Antigen (CD34) in Lipomatous TumorsAmerican Journal of Surgical Pathology, 1997
- Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma☆, ☆☆, ★Journal of the American Academy of Dermatology, 1997
- Dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1996
- CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re‐excisional specimens of dermatofibrosarcoma protuberansJournal of Cutaneous Pathology, 1994
- CD-34 Is Expressed by a Distinctive Cell Population in Peripheral Nerve, Nerve Sheath Tumors, and Related LesionsAmerican Journal of Surgical Pathology, 1993
- Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivoJournal of Cancer Research and Clinical Oncology, 1992
- Cutaneous Ulceration Due to Contrast ExtravasationInvestigative Radiology, 1991